Articles dans des revues avec comité de lecture (233)
  1. 174. Place, I., Laruelle, C., & Englert, Y. (1997). Construire de manière assistée une cellule familiale. Cahiers de psychologie clinique, 9, 305-325.
  2. 175. Englert, Y., Rodesch, C., Van Den Bergh, M. J., & Bertrand, E. (1996). Oocyte shortage for donation may be overcome in a programme with anonymous permutation of related donors. Human reproduction, 11(11), 2425-2428.
  3. 176. Englert, Y. (1996). Oocyte donation: Ethics of oocyte donation are challenged by the health care system. Human reproduction, 11(11), 2353-2355.
  4. 177. Hollemaert, S., Wautrecht, J.-C., Capel, P., Abramowicz, M., Englert, Y., & Delbaere, A. (1996). Thrombosis associated with ovarian hyperstimulation syndrome in a carrier of the factor V Leiden mutation. Thrombosis and haemostasis, 76(2), 275-277.
  5. 178. Govaerts, I., Koenig, I., Van Den Bergh, M. J., Bertrand, E., Revelard, P., & Englert, Y. (1996). Is intracytoplasmic sperm injection (ICSI) a safe procedure? What do we learn from early pregnancy data about ICSI? Human reproduction, 11(2), 440-443.
  6. 179. Bertrand, E., Van Den Bergh, M. J., & Englert, Y. (1996). Clinical parameters influencing human zona pellucida thickness. Fertility and sterility, 66(3), 408-411.
  7. 180. Laruelle, C., & Englert, Y. (1996). Devenir des embryons surnuméraires et risque de grossesse multiple en fécondation in vitro : Qu'en pensent les couples concernés ? Revue médicale de Bruxelles, 17(3), 115-119.
  8. 181. Bertrand, E., Devreker, F., Van Den Bergh, M. J., & Englert, Y. (1996). Is the subzonal-insemination procedure an efficient technique in the treatment of extreme oligoasthenoteratozoospermia? European journal of morphology, 34(4), 245-255. doi:10.1076/ejom.34.4.245.13042
  9. 182. Mawissa, D., Legreve, A., Ragon, Y., Birmane, J., & Englert, Y. (1996). Evaluation des methodes de preparation du sperme pour la fecondation in vitro humaine. Journal de gynécologie obstétrique et biologie de la reproduction, 25(6), 577-581.
  10. 183. Delbaere, A., Bergmann, P., Gervy Decoster, C., Deschodt Lanckman, M., De Maertelaer, V., & Englert, Y. (1996). Periovulatory elevation of angiotensin II in the peritoneal fluid during the human menstrual cycle. The Journal of clinical endocrinology and metabolism, 81(8), 2810-2815. doi:10.1210/jc.81.8.2810
  11. 184. Delbaere, A., Englert, Y., Bergmann, P., De Prez, E., Giot, J. M., & Deschodt Lanckman, M. (1996). Bioactive angiotensin (1-8) is the main component of angiotensin II immunoreactivity in human follicular fluid. Peptides, 17(7), 1135-1138. doi:10.1016/S0196-9781(96)00184-2
  12. 185. Devreker, F., Govaerts, I., Bertrand, E., Van Den Bergh, M. J., Gervy, C., & Englert, Y. (1996). The long-acting gonadotropin-releasing hormone analogues impaired the implantation rate. Fertility and sterility, 65(1), 122-126.
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36
    37     38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 Suivant >>